Top Markets
#1 PulseChain PulseChain +43.68%
#2 Not in Employment, Education, or Training Not in Employment, Education, or Training +6.51%
#3 Bitcoin SV Bitcoin SV +4.90%
#4 Fake World Assets Fake World Assets +4.35%
#5 eCash eCash +3.82%
#6 Shuffle Shuffle +3.57%
#7 Magma Finance Magma Finance +3.00%
#8 HOME HOME +2.48%
#9 AI XOVIA AI XOVIA +2.28%
#10 Morpho Morpho +2.27%
Coin of the day
PulseChain PulseChain
Settings
Language
ENGLISH
Currency
USD
Theme
NatureWise Biotech & Medicals Corporation NatureWise Biotech & Medicals Corporation

NatureWise Biotech & Medicals Corporation

4732
Rank in Stocks #28603
NatureWise Biotech & Medicals Corporation is a Taiwanese entity primarily... NatureWise Biotech & Medicals Corporation is a Taiwanese entity primarily engaged in the creation of pharmaceutical solutions. Its product lineup features LipoCol Forte, a capsule designed to address elevated cholesterol and triglyceride levels; PPL Taiwan green propolis; and NBM-BMX, an oral softgel formulation specifically developed for oncology treatment. The company was established in 2000 and maintains its headquarters in Taipei, Taiwan.
Share Price
$0.52945382
Last synced: 2026-08-19
Market Cap
$25.57M
Change (1 day)
0.30%
Change (1 year)
-25.57%
Country
TW
Trade NatureWise Biotech & Medicals Corporation (4732)

Category

Healthcare
Earnings for NatureWise Biotech & Medicals Corporation (4732)
Earnings in 2026 TTM: 0
According to NatureWise Biotech & Medicals Corporation latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for NatureWise Biotech & Medicals Corporation from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH